Treace Medical Concepts (TMCI) Gains from Investment Securities (2020 - 2026)

Treace Medical Concepts has reported Gains from Investment Securities for 7 years, with the latest figure at -$587000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities fell 204.7% year-over-year to -$587000.0; the trailing twelve-month figure through Mar 2026 stood at $105000.0 (down 81.27% YoY), and the FY2025 full-year result was $7.2 million, down 7.62% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at -$587000.0, down from $599000.0 in the prior quarter.
• The five-year high for Gains from Investment Securities was $3.4 million in Q3 2024, with the low at -$587000.0 in Q1 2026.
• Historically, Gains from Investment Securities has averaged $950206.7 across 5 years, with a median of $625198.0 in 2023.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities jumped 561.39% — and 2026, when it slumped 204.7%.
• Treace Medical Concepts' Gains from Investment Securities stood at $121000.0 in 2022, then jumped by 321.16% to $509600.0 in 2023, then sank by 81.75% to $93000.0 in 2024, then surged by 544.09% to $599000.0 in 2025, then slumped by 198.0% to -$587000.0 in 2026.
• The last three Gains from Investment Securities figures came in at -$587000.0 (Q1 2026), $599000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.